PDGF, CD154 and/or CCL2.73–75 Conversely, fibroblasts and macrophages are important sources of CCL2 and HGF,76,77 which act on cancer cells to increase CCR2 and MET signaling during DCIS progression. The gene discussed is CCR2; the disease is ductal breast carcinoma in situ.